|
Feb 17
|
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q3 2025 Earnings Call Highlights: Strong ...
|
|
Feb 15
|
GSK shares shorted by leading U.S. hedge fund, The Times reports
|
|
Feb 15
|
Here's Why We're Wary Of Buying GSK's (LON:GSK) For Its Upcoming Dividend
|
|
Feb 14
|
Hedge fund Citadel takes short position in GSK, FT reports
|
|
Feb 13
|
ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis
|
|
Feb 12
|
Some May Be Optimistic About GSK's (LON:GSK) Earnings
|
|
Feb 11
|
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
|
|
Feb 10
|
Recent uptick might appease GSK plc (LON:GSK) institutional owners after losing 7.8% over the past year
|
|
Jan 4
|
GSK’s Nucala Gains Approval in China for CRSwNP
|
|
Jan 3
|
GSK's Sinus Disease Drug Secures Approval In China
|
|
Dec 30
|
Can GSK plc (LON:GSK) Maintain Its Strong Returns?
|
|
Sep 30
|
GSK plc (NYSE:GSK) Doesn’t Rank Too High In The List Of The Best Global Stocks To Buy
|
|
Jul 24
|
GSK (GSK) Earnings Expected to Grow: Should You Buy?
|
|
Jun 16
|
The $3bn crisis casting a shadow over Dame Emma Walmsley’s GSK
|
|
Jun 16
|
The heartburn drug giving British pharma giant GSK a $3bn headache
|
|
Mar 25
|
With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional owners
|
|
Mar 24
|
12 Best Biotech Penny Stocks to Invest In
|
|
Mar 24
|
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
|
|
Mar 19
|
Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale
|
|
Mar 19
|
Pfizer Sells $3.5 Billion of Shares in Haleon
|